Prevention drugs is a big market. Gilead just developed a prevention for HIV.
CNBC interview below. (if link doesn't work google the headline title ' Gilead Sciences CEO on FDA approval of Yeztugo: A milestone moment in the history of HIV'
https://www.cnbc.com/video/2025/06/23/gilead-sciences-ceo-on-fda-approval-of-yeztugo-a-milestone-moment-in-the-history-of-hiv.html
Prevention drugs is a big market. Gilead just developed a...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $31.87M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 13.5¢ | 13.5¢ | $2.313K | 17.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 392891 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 884 | 1 |
View Market Depth
| Last trade - 11.12am 26/06/2025 (20 minute delay) ? |
| ILA (ASX) Chart |